New Key Statistics Module, Z-Score and F-Score
SZSE:301230 Key Ratios
Market Cap ¥ M | 3,170.01 |
Enterprise Value ¥ M | 3,201.18 |
P/E(ttm) | 122.76 |
PE Ratio without NRI | 110.24 |
Forward PE Ratio | -- |
Price/Book | 2.87 |
Price/Sales | 6.53 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 1.87 |
Revenue (TTM) ¥ M | 499.00 |
EPS (TTM) ¥ | 0.18 |
Beneish M-Score | -1.95 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 20.90 |
y-y EBITDA Growth Rate % | -70.90 |
EV-to-EBIT | 113.48 |
EV-to-EBITDA | 113.48 |
PEG | 5.27 |
Shares Outstanding M | 139.59 |
Net Margin (%) | 5.21 |
Operating Margin % | 4.43 |
Pre-tax Margin (%) | 4.29 |
Quick Ratio | 3.64 |
Current Ratio | 3.96 |
ROA % (ttm) | 1.83 |
ROE % (ttm) | 2.33 |
ROIC % (ttm) | 3.72 |
Dividend Yield % | 1.45 |
Altman Z-Score | 7.06 |
SZSE:301230 Number of Guru Trades
SZSE:301230 Volume of Guru Trades
Gurus Latest Trades with SZSE:301230
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301230 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Pharma Resources (Shanghai) Co Ltd Insider Transactions
No Available Data